PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410586
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410586
The global geriatric population is on the rise, and with it, the demand for advanced devices and equipment to address the healthcare needs of aging individuals is increasing exponentially. Additionally, the growing per capita income in both developed and developing regions is driving the adoption of advanced medical devices for the treatment of a wide range of diseases. Manufacturers of nebulizer devices are experiencing a shift in production to emerging economies, thanks to the easy availability of land and cost-effective manufacturing options.
The shift in nebulizer device production is primarily attributed to the availability of affordable land in developing regions. Leading companies like Koninklijke Philips N.V., Becton, Dickinson and Company, and others have already established manufacturing plants in countries like India, while several other companies are exploring similar opportunities in these growing markets.
The nebulizer devices market in North America is thriving due to continuous technological innovation. The fast-paced lifestyle in the region has led to increased demand for portable nebulizer devices, especially among patients with conditions such as asthma and other respiratory diseases like bronchitis and pneumonia.
Newly launched nebulizers with quick drug delivery and advanced technological features are gaining popularity in the United States. For instance, Omron Healthcare, Inc. introduced the Portable MicroAir Nebulizer device, which boasts super-small nebulizers equipped with Vibrating Mesh Technology, weighing only 6 oz, and discreetly fitting in one's palm.
Inspired by such innovations, companies in the market are developing portable devices suitable for newborns with respiratory issues such as COPD (Chronic Obstructive Pulmonary Disease) and asthma. These nebulizer devices are powered by rechargeable batteries, and a variety of masks are available for use in neonatal cases.
The Asia Pacific region is emerging as a formidable contender in the nebulizer devices market, driven by the increasing prevalence of Chronic Obstructive Pulmonary Disease (COPD). COPD, a progressive lung disorder, affects millions in the region, with high prevalence rates in countries like China and India.
According to the Journal of Thoracic Disease, COPD prevalence in China is 8.2%, attributed to increased exposure to biomass smoke. India witnesses an estimated 500,000 deaths annually due to COPD, according to the Journal of Lung, Pulmonary & Respiratory Research. In New Zealand, COPD affects 10% to 17% of the total population, as reported by the World Health Organization. In Australia, 7.5% of individuals above 40 years of age suffer from COPD, according to the Lung Foundation Australia.
The rising disposable income in the Asia Pacific region is enabling consumers to afford advanced medical technologies and opt for better treatment options. Consequently, the demand for nebulizer devices in the Asia-Pacific region is expected to surge in the years to come.
As the nebulizer devices market continues to evolve and expand globally, it is poised to play a pivotal role in enhancing respiratory health and improving the lives of individuals suffering from various lung conditions.